GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19)
Clinical trial NCT04673149 · COMPLETED
Trial details
- NCT number
- NCT04673149
- Sponsor
- GeneOne Life Science, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-31
- Primary completion
- 2021-03-03
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.